Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 40,791 | 45,789 | 35,442 | 11,355 | 55,742 |
| Marketable Securities | 14,990 | 2,016 | 50 | 46,520 | 2,616 |
| Receivables | 891 | 638 | 745 | 297 | 50,840 |
| TOTAL | $59,157 | $50,997 | $38,441 | $60,000 | $111,549 |
| Non-Current Assets | |||||
| PPE Net | 2,566 | 2,251 | 2,245 | 5,673 | 4,872 |
| Intangibles | 42,372 | 57,212 | 57,234 | 57,364 | 57,494 |
| Other Non-Current Assets | 8,489 | 2,758 | 3,099 | 627 | 630 |
| TOTAL | $53,427 | $62,221 | $62,578 | $63,664 | $62,996 |
| Total Assets | $112,584 | $113,218 | $101,019 | $123,664 | $174,545 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,181 | 5,437 | 6,270 | 8,608 | 27,969 |
| Other current liabilities | 3,333 | 7,388 | N/A | N/A | 197 |
| TOTAL | $11,367 | $13,977 | $17,960 | $18,981 | $47,116 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 10,808 | 9,421 | 18,119 |
| Other Non-Current Liabilities | 45,274 | 7,429 | 1,972 | 2,942 | 2,222 |
| TOTAL | $57,871 | $22,229 | $21,036 | $32,747 | $36,531 |
| Total Liabilities | $69,238 | $36,206 | $38,996 | $51,728 | $83,647 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 249,088 | 228,356 | 188,534 | 170,146 | 169,709 |
| Common Shares | 515,467 | 484,722 | 451,343 | 440,280 | 434,529 |
| Retained earnings | -466,998 | -403,465 | -384,856 | -363,370 | -337,097 |
| Other shareholders' equity | -5,123 | -4,245 | -4,464 | -4,974 | -6,534 |
| TOTAL | $43,346 | $77,012 | $62,023 | $71,936 | $90,898 |
| Total Liabilities And Equity | $112,584 | $113,218 | $101,019 | $123,664 | $174,545 |